Dallas Renal Group is a clinical research site located in Dallas, Texas, United States 75230.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
Dallas Renal Group has participated in 11 clinical trials with 7 currently active.
Therapeutic areas: IgA Nephropathy, Kidney Disease, Arteriovenous Fistula.
Sponsors: Novartis Pharmaceuticals, Takeda, C. R. Bard.
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Dallas Renal Group has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dallas Renal Group has 11 clinical trials on record, with 7 currently active. Their work covers IgA Nephropathy, Kidney Disease, Arteriovenous Fistula.
Yes — Dallas Renal Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.